戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cing following biochemical identification as Pasteurella.
2 glycosyltransferase proteins found in Type D Pasteurella.
3 ne-associated isolates (P. dagmatis [n = 2], Pasteurella canis [n = 2], and N. canis [n = 1]) are dis
4                                              Pasteurella canis was the most common isolate of dog bit
5 ourse of inflammation following experimental Pasteurella challenge was altered in C2D recipients.
6 uld help clinicians to make the diagnosis of Pasteurella conjunctivitis in every day practice.
7                                              Pasteurella dagmatis and Neisseria canis were repeatedly
8 differences in the active sites of these two Pasteurella enzymes.
9  other members of Haemophilus-Actinobacillus-Pasteurella family, where genetic manipulation is limite
10 lycosyltransferases, EXT1 and 2, or to other Pasteurella glycosaminoglycan synthases that produce hya
11                                          The Pasteurella HA synthase enzyme, pmHAS, catalyzes the syn
12                                            A Pasteurella haemolytica A1 gene was identified from a re
13 eningococci (GBMs), Escherichia coli K1, and Pasteurella haemolytica A2.
14 nd expression vectors that replicate both in Pasteurella haemolytica and in Escherichia coli were con
15     Twenty-four matched pairs of isolates of Pasteurella haemolytica and three matched pairs of isola
16                                            A Pasteurella haemolytica cosmid clone that activates leuk
17 nd generation of chromosomal gene fusions in Pasteurella haemolytica has been devised and used to cre
18                                              Pasteurella haemolytica is an important respiratory path
19                                              Pasteurella haemolytica is the principal bacterial patho
20           Recent reports have shown that the Pasteurella haemolytica leukotoxin (LKT) and other RTX t
21 ernatant (CCS) preparations of the RTX toxin Pasteurella haemolytica leukotoxin (LKT) contained LKT a
22                               The effects of Pasteurella haemolytica leukotoxin (LKT) on the activity
23            Exposure of bovine neutrophils to Pasteurella haemolytica leukotoxin (LKT) stimulates the
24 ciation of two other RTX toxin proteins, the Pasteurella haemolytica leukotoxin (LktA) and the entero
25                   The related RTX toxin, the Pasteurella haemolytica leukotoxin structural protein (L
26            Infection of the bovine lung with Pasteurella haemolytica results in an acute respiratory
27        Leukotoxin and endotoxin derived from Pasteurella haemolytica serotype 1 are the primary virul
28                                              Pasteurella haemolytica serotype 1 is the bacterial agen
29                                              Pasteurella haemolytica serotype 1 is the bacterium most
30                                              Pasteurella haemolytica serotype A1 (bovine strain OK) w
31 ine pulmonary surfactant is bactericidal for Pasteurella haemolytica when surfactant and bacteria mix
32 ication (R-M) system of the bovine pathogen, Pasteurella haemolytica, have been identified immediatel
33                                              Pasteurella haemolytica, the causative agent of shipping
34 e protein of the bovine respiratory pathogen Pasteurella haemolytica, was cloned, and its nucleotide
35 nary tissue after respiratory infection with Pasteurella haemolytica.
36 , Haemophilus somnus, Neisseria species, and Pasteurella haemolytica.
37  had rising antibody titers against RBCV and Pasteurella haemolytica.
38 nchial epithelium after acute infection with Pasteurella haemolytica.
39 0 and 35,000 [32K and 35K, respectively]) of Pasteurella haemolytica.
40 E from Neisseria meningitidis, and LpsA from Pasteurella haemolytica.
41                                  Mannheimia (Pasteurella) haemolytica A1 produces several virulence f
42           Leukotoxin secreted by Mannheimia (Pasteurella) haemolytica binds to the intact signal pept
43     Leukotoxin (Lkt) secreted by Mannheimia (Pasteurella) haemolytica is an RTX toxin which is specif
44 bility of ruminant leukocytes to Mannheimia (Pasteurella) haemolytica leukotoxin (Lkt).
45 otoxin structural gene (lktA) of Mannheimia (Pasteurella) haemolytica was investigated by nucleotide
46  of OmpA were investigated in 31 Mannheimia (Pasteurella) haemolytica, 6 Mannheimia glucosida, and 4
47 lktC, lktB, and lktD genes in 23 Mannheimia (Pasteurella) haemolytica, 6 Mannheimia glucosida, and 4
48 eptor for leukotoxin secreted by Mannheimia (Pasteurella) haemolytica.
49 onsisting of various portions of both of the Pasteurella heparosan synthases in a single polypeptide
50 sma isolates or from the Acholeplasma or the Pasteurella isolates, demonstrating a high degree of spe
51  PASTEURELLA: Of the more than 17 species of Pasteurella known, Pasteurella multocida subsp. multocid
52 that the 39-kDa cross-protective protein was Pasteurella lipoprotein B, or PlpB.
53                            The leukotoxin of Pasteurella (Mannheimia) haemolytica is believed to play
54                                              Pasteurella (Mannheimia) haemolytica leukotoxin (Lkt) ca
55  The intracellularly acting protein toxin of Pasteurella multocida (PMT) causes numerous effects in c
56     Neuraminidases produced by 16 strains of Pasteurella multocida (serotypes 1 to 16) were character
57 c nonfastidious species were as follows: for Pasteurella multocida and staphylococci tested on Muelle
58 ents were conducted with a zoonotic pathogen Pasteurella multocida and the fluoroquinolone enrofloxac
59 zae, Proteus mirabilis, Vibrio fischeri, and Pasteurella multocida are all cleaved by RNase III as pr
60      Bordetella bronchiseptica and toxigenic Pasteurella multocida are the etiologic agents of swine
61 ly potent against the Gram-negative pathogen Pasteurella multocida both in vitro and in a mouse infec
62 eir potencies against the bacterial pathogen Pasteurella multocida both in vitro and in mouse infecti
63                    The fowl cholera pathogen Pasteurella multocida Carter Type A also produces HA in
64                             The pnhA gene of Pasteurella multocida encodes PnhA, which is a member of
65 oop sequences from Enterococcus faecalis and Pasteurella multocida gamma-GCS-GS, isoforms that are in
66                                  To identify Pasteurella multocida genes that are differentially expr
67                                          The Pasteurella multocida HA synthase, pmHAS, a polymerizing
68 gmented genomic DNA from the animal pathogen Pasteurella multocida has identified a gene encoding a p
69 P]UDP products made by the purified class II Pasteurella multocida HAS were not released by adding un
70            Outer membrane proteins (OMPs) of Pasteurella multocida have various functions related to
71                                          The Pasteurella multocida heparosan synthases, PmHS1 and PmH
72                                          The Pasteurella multocida hyaluronan synthase (PmHAS) cataly
73  the literature, of ocular infections due to Pasteurella multocida include: endophtalmitis, keratitis
74                                              Pasteurella multocida is a bacterial pathogen that cause
75                                              Pasteurella multocida is a mucosal pathogen that coloniz
76                                              Pasteurella multocida is a rare cause of neonatal bacter
77                                              Pasteurella multocida is a small nonmotile gram-negative
78                                              Pasteurella multocida is a zoonotic Gram-negative cocco-
79                            As infection with Pasteurella multocida is common in rabbits, an enzyme im
80                                              Pasteurella multocida is composed of three subspecies th
81 e rapid, accurate method to detect toxigenic Pasteurella multocida is needed for improved clinical di
82        The dermatonecrotic toxin produced by Pasteurella multocida is one of the most potent mitogeni
83                                              Pasteurella multocida is the causative agent of a wide r
84                                              Pasteurella multocida isolates with enrofloxacin MIC of
85 enes encoding Haemophilus influenzae D15 and Pasteurella multocida Oma87 protective outer membrane an
86 hase, PmCS, from the Gram-negative bacterium Pasteurella multocida polymerize the glycosaminoglycan (
87                         Toxigenic strains of Pasteurella multocida produce a 146 kDa toxin (PMT) that
88 isolates and 4 attenuated vaccine strains of Pasteurella multocida recovered from multiple avian spec
89               We present a case of fulminant Pasteurella multocida sepsis in a 66-year-old man who ha
90                    Fowl cholera is caused by Pasteurella multocida serovars A:1, A:3, and A:4.
91 -ray crystal structures of a multifunctional Pasteurella multocida sialyltransferase (Delta24PmST1) w
92 he structures of a truncated multifunctional Pasteurella multocida sialyltransferase (Delta24PmST1),
93                                              Pasteurella multocida strains isolated from 15 pigs with
94 ntical for P. multocida subsp. multocida and Pasteurella multocida subsp. gallicida but differs from
95 e more than 17 species of Pasteurella known, Pasteurella multocida subsp. multocida and Pasteurella m
96                                              Pasteurella multocida subsp. multocida is a commensal an
97 , Pasteurella multocida subsp. multocida and Pasteurella multocida subsp. septica are among the most
98  mediates adhesion of serogroup A strains of Pasteurella multocida to elicited turkey air sac macroph
99 as assessed by exposing broth suspensions of Pasteurella multocida to perflubron for various times.
100 agonists and phospholipase C is activated by Pasteurella multocida toxin (a G(q) alpha-subunit agonis
101                           We have shown that Pasteurella multocida toxin (PMT) directly causes transi
102                                              Pasteurella multocida toxin (PMT) has been hypothesized
103                                              Pasteurella multocida toxin (PMT) is a potent mitogen fo
104                                              Pasteurella multocida toxin (PMT) is a potent mitogen kn
105                                          The Pasteurella multocida toxin (PMT) is a potent mitogen wh
106 atalytic and receptor-binding domains of the Pasteurella multocida toxin (PMT) were investigated.
107 not obvious and is explored with recombinant Pasteurella multocida toxin (rPMT, a Galpha(q) agonist).
108 ion on its own, it potentiated the effect of Pasteurella multocida toxin by 2-fold and ionomycin by 3
109 quires protein kinase C and MEK activity) by Pasteurella multocida toxin, a Galpha(q) agonist that pr
110 er these conditions, treatment of cells with Pasteurella multocida toxin, a selective inhibitor of Ga
111 channel current inhibition was diminished by Pasteurella multocida toxin, mimicked by constitutively
112                                These include Pasteurella multocida toxin, which uniquely acts as a mi
113 otein ChaN, and an uncharacterized domain of Pasteurella multocida toxin.
114 ogous to the membrane targeting C1 domain of Pasteurella multocida toxin.
115 des tryptophanase; as well as a homologue of Pasteurella multocida tsaA, which encodes an alkyl perox
116 in a single polypeptide as was found for the Pasteurella multocida Type A PmHAS, the hyaluronan synth
117            Heparosan synthase 1 (PmHS1) from Pasteurella multocida Type D is a dual action glycosyltr
118                                              Pasteurella multocida Type D, a causative agent of atrop
119 noculated intranasally with 9 x 10(7) CFU of Pasteurella multocida type D.
120                                              Pasteurella multocida Type F, the minor fowl cholera pat
121 The extracellular polysaccharide capsules of Pasteurella multocida types A, D, and F are composed of
122 ue of the NeuA C-terminal domain (Pm1710) in Pasteurella multocida was also shown to be an esterase,
123                                              Pasteurella multocida was grown in iron-free chemically
124 ytica and three matched pairs of isolates of Pasteurella multocida were isolated by using a nasal swa
125   The major outer membrane protein (OmpH) of Pasteurella multocida X-73 was purified by selective ext
126                                       Type A Pasteurella multocida, a prevalent animal pathogen, empl
127 l pathogens, including Haemophilus parasuis, Pasteurella multocida, Actinobacillus pleuropneumoniae,
128  Synechocystis sp., Deinococcus radiodurans, Pasteurella multocida, and Actinobacillus actinomycetemc
129 ose of Salmonella enterica, Vibrio cholerae, Pasteurella multocida, and Haemophilus influenzae.
130            Fowl cholera, a disease caused by Pasteurella multocida, continues to be a major problem f
131 tein, PfhB2, from the opportunistic pathogen Pasteurella multocida, in our analysis.
132  bacteria, including Haemophilus influenzae, Pasteurella multocida, Neisseria gonorrhoeae, Neisseria
133 se of rapidly evolving conjunctivitis due to Pasteurella multocida, occurring after direct inoculatio
134 e genome sequence of a common avian clone of Pasteurella multocida, Pm70.
135 an synthases from the Gram-negative bacteria Pasteurella multocida, PmHS1 and PmHS2, were efficiently
136 5 from Haemophilus influenzae and Oma87 from Pasteurella multocida.
137 ia meningitidis, Haemophilus influenzae, and Pasteurella multocida.
138 nia pestis and the human and animal pathogen Pasteurella multocida.
139 tion of the pig's upper respiratory tract by Pasteurella multocida.
140 ilus influenzae, Neisseria meningitidis, and Pasteurella multocida.
141 ely related species, Actinobacillus suis and Pasteurella multocida.
142 acteria including Haemophilus influenzae and Pasteurella multocida.
143 Haemophilus spp., Neisseria gonorrhoeae, and Pasteurella multocida.
144 the second most common site of infection for PASTEURELLA: Of the more than 17 species of Pasteurella
145       The 35K and 32K major OMPs, designated Pasteurella outer membrane proteins A and B (PomA and Po
146 induced periodontitis ( n = 6-7/group) where Pasteurella pneumotropica ( Pp)-reactive immune response
147 ally infected by the opportunistic bacterium Pasteurella pneumotropica.
148 plex microbiologic mix that usually includes pasteurella species but may also include many other orga
149 lity testing were performed on 73 strains of Pasteurella species isolated from human infections and o
150                                              Pasteurella species were the most frequent isolates from
151 ear reliable for testing susceptibilities of Pasteurella species.
152  American Type Culture Collection strains of Pasteurella species.
153 ences of the D15-related proteins from other Pasteurella spp.
154               Two and 17 cattle nasally shed Pasteurella spp. before and after transport, respectivel
155 espiratory tract infections with viruses and Pasteurella spp. were determined sequentially among 26 c
156 ive of the 26 lung samples were positive for Pasteurella spp., and their CFU ranged between 4.0 x 10(
157 longs to the HAP (Haemophilus-Actinobacillus-Pasteurella) theta replicon family.
158 ) haemolytica, 6 Mannheimia glucosida, and 4 Pasteurella trehalosi strains by comparative nucleotide
159 ) haemolytica, 6 Mannheimia glucosida, and 4 Pasteurella trehalosi strains.
160 two related species Mannheimia glucosida and Pasteurella trehalosi, and four contain recombinant segm
161 cal Subject Headings Francisella tularensis, Pasteurella tularensis, biological weapon, biological te

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top